The Centre for Menstrual Cycle and Ovulation Research (CeMCOR), located at VGH, is celebrating its tenth year of health research, care, and knowledge translation in women's health.
As one of the only research programs in North America -- and possibly the world -- with a focus on ovulation and the effects disturbances on women's overall health, CeMCOR has been instrumental in shifting ideas around women's health.
Lead by founder and scientific director, Dr. Jerilynn Prior, CeMCOR was the first to show that progesterone is an effective treatment for hot flush; that progesterone treatment for menopause comes with fewer cardiovascular heath risks than estrogen treatment; and through their work, they have brought new understanding of the perimenopause phase of life and potential complications and treatments.
A key component of CeMCOR's women's health research is the Centre's strength in and priority for knowledge translation -- bringing information to healthcare practitioners and to patients, family, and friends. They are well known for their accessible and informative website. For more information, visit www.cemcor.ca.